Thymoma Clinical Trial - Efficacy of Octreotide Treatment in Patients With

See also
Status	Clinical Trial	Phase
Recruiting	`NCT01950572` - Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Terminated	`NCT00818090` - Paclitaxel and Cisplatin for Thymic Neoplasm	Phase 2
Completed	`NCT00921739` - Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies	Phase 1
Recruiting	`NCT05255965` - IL-8+ naïve T Cells as a Biomarker for Thymoma Identification
Withdrawn	`NCT02948855` - Regulation of LncRNA For Breg in Patients With Thymoma and Autoimmune Diseases
Completed	`NCT00387868` - Preoperative Treatment of Patients With High Risk Thymoma	Phase 2
Completed	`NCT01272817` - Nonmyeloablative Allogeneic Transplant	N/A
Recruiting	`NCT03466827` - Selinexor in Patients With Advanced Thymoma and Thymic Carcinoma	Phase 2
Completed	`NCT02220855` - A Study of BKM120 (Buparlisib) in Relapsed or Refractory Thymomas	Phase 2
Completed	`NCT03288662` - Relationship Between Computed Tomography Manifestation and Histopathological Classification of Thymic Epithelial Tumors	N/A
Active, not recruiting	`NCT01242072` - Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies	Phase 1
Recruiting	`NCT06029621` - Robot-assisted vs VATS for Thymoma	N/A
Active, not recruiting	`NCT03921671` - Ramucirumab and Carbo-Paclitaxel for Untreated Thymic Carcinoma / B3 Thymoma With Carcinoma (RELEVENT)	Phase 2
Active, not recruiting	`NCT01621568` - Sunitinib for Advanced Thymus Cancer Following Earlier Treatment	Phase 2
Recruiting	`NCT05262582` - Comparison of Single Port and Two Ports Robotic Assisted Thoracic Surgery for Thymectomy	N/A
Terminated	`NCT01100944` - A Phase 1/2 Study of PXD101 (Belinostat) in Combination With Cisplatin, Doxorubicin and Cyclophosphamide in the First Line Treatment of Advanced or Recurrent Thymic, Malignancies	Phase 1/Phase 2
Active, not recruiting	`NCT03968315` - An Investigational Scan (MRI) in Imaging Patients With Newly-Diagnosed or Recurrent Thymoma	N/A
Recruiting	`NCT04162691` - Single Cell Sequencing Analysis of Thymoma
Recruiting	`NCT06086327` - Application of 68Ga-Pentixafor PET/CT for Thymoma	Early Phase 1
Completed	`NCT01364727` - A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic Malignancies	Phase 2

NCT number	NCT00332969
Study type	Interventional
Source	Novartis
Contact
Status	Completed
Phase	Phase 2
Start date	September 2005

Efficacy of Octreotide Treatment in Patients With Primary Inoperable Thymoma

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms